Comparison of Four Strong Acids on the Precipitation Potential of Gypsum in Brines During Distillation of Pretreated, Augmented Urine by Muirhead, Dean & Carrier, Christopher
  
 
 
 
 
 
 
 
 
Comparison of Four Strong Acids on the Precipitation Potential of Gypsum in 
Brines during Distillation of Pretreated, Augmented Urine 
 
 
 
 
By Dean Muirhead and Christopher Carrier 
 
 
 
 
Paper to be submitted to ICES 2012 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
https://ntrs.nasa.gov/search.jsp?R=20120008949 2019-08-30T20:26:44+00:00Z
 ii 
Abstract 
In this study, three different mineral acids were substituted for sulfuric acid (H2SO4) in 
the urine stabilizer solution to eliminate the excess of sulfate ions in pretreated urine 
and assess the impact on maximum water recovery to avoid precipitation of minerals 
during distillation.  The study evaluated replacing 98% sulfuric acid with 85% phosphoric 
acid (H3PO4), 37% hydrochloric acid (HCl), or 70% nitric acid (HNO3).  The effect of 
lowering the oxidizer concentration in the pretreatment formulation also was studied.  
This paper summarizes the test results, defines candidate formulations for further study, 
and specifies the injection masses required to stabilize urine and minimize the risk of 
mineral precipitation during distillation. In the first test with a brine ersatz acidified with 
different acids, the solubility of calcium in gypsum saturated solutions was measured.  
The solubility of gypsum was doubled in the brines acidified with the alternative acids 
compared to sulfuric acid.  In a second series of tests, the alternative acid pretreatment 
concentrations were effective at preventing precipitation of gypsum and other minerals 
up to 85% water recovery from 95th-percentile pretreated, augmented urine.  Based on 
test results, phosphoric acid is recommended as the safest alternative to sulfuric acid.  It 
also is recommended that the injected mass concentration of chromium trioxide solution 
be reduced by 75% to minimize liquid resupply mass by about 50%, reduce toxicity of 
brines, and reduce the concentration of organic acids in distillate.  The new stabilizer 
solution formulations and required doses to stabilize urine and prevent precipitation of 
minerals up to 85% water recovery are given.  The formulations in this study were 
tested on a limited number of artificially augmented urine batches collected from 
employees at the Johnson Space Center (JSC).  This study successfully demonstrated 
that the desired physical and chemical stability of pretreated urine and brines can be 
achieved using alternate pretreatment formulations under laboratory conditions.  
Additional testing and hazard assessments will be required to determine the feasibility 
of utilizing the proposed urine pretreatment formulations on ISS. 
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1. INTRODUCTION 
The Urine Processor Assembly (UPA) was introduced on the International Space 
Station (ISS) in 2008 in order to recover potable water from urine and reduce the 
required resupply mass of water.  In October 2009, on-orbit operation of the UPA at 
85% water recovery of pretreated urine caused precipitates that were identified as 
gypsum (CaSO4·2H2O).  The precipitates blocked pitot tubes within the Distillation 
Assembly (DA) and flooded the DA with brine that led to failure of the UPA.  The 
gypsum precipitates, which were not observed in extensive ground testing, were 
attributed to both elevated in-flight levels of urinary calcium and sulfate ions and excess 
sulfate from the sulfuric acid (H2SO4) in the pretreatment formulation.  The Russian 
pretreatment formulation, used in the Russian-provided waste collection system, uses 
sulfuric acid and hexavalent chromium as an oxidizer in the form of chromium trioxide 
(CrO3).  The UPA currently operates at 70% water recovery to minimize the precipitation 
potential in the DA.  At 70% water recovery, only 62% of the urine mass is recovered as 
water from nominally pretreated urine. 
Initial testing compared three strong acids to sulfuric acid in the pretreatment stabilizer 
solution formulation.  The solubility of calcium in brines pretreated with the three acids 
was measured and compared to the baseline sulfuric acid formulation.  The success 
criterion was full solubility of all organics and minerals at 85% water recovery from 
95th-percentile Pretreated Augmented Urine (PTAU95) with nominal pretreatment dosing 
of about 88 doses per EDV-y (pretreated urine storage container on ISS)  The testing 
was conducted utilizing an estimated 95th-percentile calcium concentration of 0.26 g 
dissolved calcium per liter of raw urine based on analysis of wastewater sampled from 
nine returned Recycle Filter Tank Assemblies (RFTAs) (Gazda, 2010). 
This work focused on measuring the chemical and physical properties of pretreated 
urine and brines and assessing the relationship between the pretreatment chemicals 
and the precipitation potential of minerals during distillation and storage. 
The goal of this research was to maximize the mass of water that can be extracted from 
urine by distillation processors in microgravity. The overall objective of this series of 
tests was to optimize the pretreatment formulation to maximize water recovery without 
mineral precipitation while minimizing the required mass of pretreatment chemicals to 
stabilize urine for storage.  The test variables were the type of acid, the concentration of 
the acid, and the concentration of the oxidizer. 
 
Specific objectives were as follows: 
 Quantify the ability of alternative strong acids to minimize the common ion effect and 
increase the solubility of calcium and minerals in brines. 
 Optimize the oxidizer dosing concentration to prevent uric acid precipitation and 
improve distillate water quality while minimizing consumables and hazard levels. 
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 Using data from the first two objectives, define the required pretreatment formulation 
and dose that stabilizes urine and minimizes precipitation risks during distillation. 
 
2. EXPERIMENTAL METHODS 
2.1 SELECTED ACIDS TO REPLACE SULFURIC ACID 
The three strong acids used as substitutes for sulfuric acid are listed in Table 1. 
Table 1:  Acids Used in Testing 
Acid, Purity Advantages Disadvantages 
Sulfuric, 98% Keeps surfaces clean, 
decades of flight experience, 
very low vapor pressure 
Excessive sulfate decreases 
calcium solubility in brines, has 
high reactivity 
Hydrochloric, 37% Increased calcium sulfate 
solubility 
Fuming, corrosive, not 
compatible with hexavalent 
chromium 
Nitric, 70% Increased calcium sulfate 
solubility 
Unstable when exposed to air 
and light, corrosive, forms 
ammonium nitrate salts 
Phosphoric, 85% Increased calcium sulfate 
solubility, low toxicity, provides 
buffering at pH 2 
Weak acid, large dose required 
to reach pH = 2, decreased 
solubility of phosphates 
 
2.2 PREPARATION OF HEXAVALENT CHROMIUM OXIDIZER SOLUTION 
In addition to the mineral acids, an oxidizer solution was prepared, as part of the 
stabilizer solution that is added to urine. The oxidizer concentration (0.015 M in 
pretreated urine) currently used on ISS was used as a baseline stabilizer.  The oxidizer 
solution was prepared by adding 165 g of CrO3 to 1,000 g of Deionized (DI) water, using 
the safety procedures and preparation methods described in EC3-WR-088, Standard 
Operating Procedure for the Formulation of Batch Russian Pretreated Urine.  The 
resulting solution had a mass density of 1.17 g/mL.  A 0.004 M CrO3 solution was also 
tested.  For the reduced oxidizer dose, 41 g of CrO3 were added to 1,000 g of DI water.  
The mass density of the reduced oxidizer solution was 1.04 g/mL.  The reduced oxidizer 
dose was found to be effective at stabilizing urine by Putnam (1971). 
2.3 EXPERIMENTS 
Two types of experiments were conducted to compare the effectiveness of alternative 
pretreatment formulations to stabilize urine and prevent precipitation of gypsum during 
distillation.  In the first test, the solubility of gypsum was measured in brine ersatz at a 
range of acid doses (pH values).  In the second test, augmented human urine was 
pretreated with the alternate acids to provide the same pH as the baseline pretreatment 
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dose.  The pretreated urine was distilled to 85% water recovery.  The brines were 
stored for 1 week and analyzed to measure the solubility of calcium and the mass 
concentration of suspended solids (precipitates). 
Table 2:  Summary of Tests to Evaluate Alternative Pretreatment Formulations 
Test Solution 
Test 1 85% brine ersatz 
Test 2 85% brine distilled from acidified and oxidized PTAU95 
2.3.1 Test 1:  Solubility of Gypsum in Brine Ersatz 
In Test 1, saturated solutions of gypsum were prepared by adding an excess of gypsum 
crystals to the solution of interest.  The ersatz solutions represented brines with urinary 
organic and inorganic compounds.  The solution was stirred for 7 days to reach 
chemical and physical equilibrium.  The saturated solution was filtered using glass fiber 
filters (0.7 micron pore size), and the filtrate was analyzed by ion chromatography for 
total dissolved calcium and sulfate concentrations. 
For this sequence of tests, on-orbit urine was simulated with a urine ersatz formulation 
developed by Verostko (2010), which has a theoretical ionic calcium concentration of 
260 mg/L, equal to the maximum urinary calcium concentration expected in-flight.  As a 
comparison, the mean urinary calcium concentration in-flight is about 188 mg/L.  The 
ersatz formulation also contains 22.5 g of urea/L of urine.  The concentration of major 
solutes in the 95th-percentile urine ersatz  and augmented urine are listed in Table 3. 
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Table 3:  Theoretical Concentrations of Major Solutes in 
95th-Percentile Urine Ersatz and Augmented Urine 
 
Cl- 
(mg/L) 
Total 
PO4 
(mg/L) 
Total 
SO4 
(mg/L) 
Na+ 
(mg/L)
Total 
Ammonia 
Nitrogen 
(TAN) 
(mg/L) 
K+ 
(mg/L)
Ca2+ 
(mg/L) 
Mg2+ 
(mg/L) 
Total 
Organic 
Carbon 
(TOC) 
(mg/L) 
Urine 
Ersatz 
Formulation 
5600 2300 3000 3000 590 2000 260 84 8500 
Augmented 
Urine: 95th 
percentile  
No 
target 3100 3000 
No 
target No target 
No 
target 260 
No 
target 9200 
2.3.2. Test 2:  Distillation of Pretreated, Augmented Human Urine 
Urine was collected from volunteers at the Johnson Space Center (JSC).  Urine was 
combined into batches, made up of 20% first morning void and 80% normal urine 
output.  Each batch of urine also corresponded to a 5:1 male:female donor ratio. 
The calcium ion concentration was measured in the raw urine prior to adding the 
augmentation chemicals.  Once the calcium concentration was measured, inorganic and 
organic chemicals were added to reach 260 mg of Ca/L of raw urine, to represent a 
worst case scenario with respect to calcium precipitation.  Other chemicals were added, 
in a linearly proportional amount, to the calcium addition, as described by Adam et al. 
(2010). 
The augmented urine was pretreated and distilled under pressure and temperature 
conditions simulating nominal operation of the DA on ISS.  The solutions used in initial 
testing represent the worst-case (most concentrated) in-flight urine solute 
concentrations.  The maximum calcium concentration was assumed to be 260 mg of 
Ca/L of raw urine, based upon a statistical analysis of in-flight urinary data.  After 
stabilization chemicals and flush water are added, the calcium concentration is reduced 
to 206 mg of Ca/L of pretreated urine. 
The theoretical mixture of urine, flush water, and stabilizer solution are given in Table 4.  
Previous ground testing at JSC and MSFC used the values in Table 4 to pretreat urine 
prior to 2010.  The values in Table 5 are an updated recipe of flushed urine based on 
RFTAs returned from ISS (Gazda, 2010).  The values in Table 5 represent the 
concentration of stabilization agent and flush water used for all testing in this report.  
The theoretical concentration of total chromium is 0.8 g-Cr/L of pretreated urine solution 
(0.015 M) using the baseline pretreatment on ISS shown in Table 5.  DI water was used 
to represent the Waste and Hygiene Compartment (WHC) flush water. 
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Table 4:  Baseline Pretreated Urine Formulation 
(used in ground testing at MSFC and JSC prior to 2010) 
Constituent Volume 
Raw urine 1 L 
Deionized (flush) water 0.25 L 
Stabilizer solution 16.7 mL 
Pretreated urine solution 1.267 L 
 
Table 5:  Pretreated Urine Formulation Based on Returned RFTAs (Gazda, 2010) 
Constituent Volume 
Raw urine 1 L 
Deionized (flush) water 0.265 L 
Stabilizer solution 15.9 mL 
Pretreated urine solution 1.281 L 
 
Prior to distillation, the pretreated urine was stored at least 1 day at ambient 
temperature (20 – 25 °C) to allow the solution to approach an equilibrium state for the 
slow oxidation-reduction processes.  The time between pretreatment and distillation was 
recorded, as the effect of storage time on precipitation potential during distillation is 
unknown. 
A rotary evaporator (Rotavapor®, Buchi model R-215) was used to distill the pretreated 
urine.  The initial mass of the pretreated urine to be distilled was measured in the glass 
evaporation flask on a 3 kg scale.  The mass was recorded to the nearest 0.1 gram.  
The initial mass of pretreated urine ranged from 300 to 500 g.  The evaporation flask 
was connected to the stop cock and vapor duct of the rotary evaporator. 
The pretreated urine was distilled under vacuum to simulate nominal DA conditions.  
The absolute pressure within the evaporation flask was maintained at 60 to 80 mbar 
and the associated vapor temperature was measured as 39 to 41 °C.  The evaporation 
vessel rotated at 45 rpm half-submerged in a heating bath, which was filled with tap 
water.  The heating bath temperature was controlled at 60 ± 5 °C nominal.  The chiller 
liquid temperature was set to 10 to 15 °C.  Distillate condensed on glass surfaces in the 
condenser and drained by gravity into the distillate collection flask.  The percent 
recovery was calculated by measuring the mass of brine solution at the end of a 
distillation run and comparing it to the initial mass of pretreated urine. 
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Following distillation to reach the targeted water recovery rate of 85%, the pressure and 
temperature were brought to ambient and the mass of the evaporation flask was 
measured; this allowed the mass of remaining brine to be determined, followed by the 
exact water recovery rate.  The brine was stored in the evaporation flask for one week 
at 25 °C to allow solid-liquid phase equilibrium by providing sufficient time for crystal 
formation if the brine was supersaturated with respect to a mineral. 
Following 1 week of storage, the mass of brine was re-measured and the mass density 
of the brine was measured with a hydrometer or in a volumetric flask on a scale.  A 
measured mass of brine was passed through a 0.7 micron glass fiber filter to measure 
Total Suspended Solids (TSS), Fixed Suspended Solids (FSS), and Volatile Suspended 
Solids (VSS) and to isolate any crystals.  The evaporation flask and the solids on the 
filter were rinsed thoroughly to collect any crystals that adhered to the flask’s glass 
surfaces.  All of the brine from the evaporation flask was passed through the filter paper.  
If the quantity of suspended solids was significant, more than one filter paper was used. 
The soluble concentration of calcium and the mass quantity of precipitates in distilled 
brines were the key parameters monitored in order to determine the reliability and 
effectiveness of the alternate acid formulations.  The main precipitate of interest for the 
given pretreatment chemicals was gypsum; other precipitates of interest were 
phosphates and uric acid. 
The masses of precipitates were monitored by measuring TSS and FSS retained on a 
glass fiber filter with an average pore size of 0.7 microns (0.6 to 0.8 microns nominal).  
The pretreated urine and brine were analyzed for TSS, FSS, and VSS.  Measuring FSS 
and VSS enabled quantification of organic and inorganic suspended solids. 
3. Results and Discussion 
3.1 TEST 1 
The solubility of gypsum in brines with both inorganic and organic constituents is shown 
in Figure 1.  Solubility of calcium acidified with the three alternative acids increases with 
decreasing pH, whereas it decreases with the baseline sulfuric acid pretreatment due to 
the common ion effect.  The overall effect of the alternative acids compared to sulfuric 
acid was a doubling in the solubility of gypsum in the ersatz brine (representing 84% 
water recovery).  Hence, there is no advantage to adding more sulfuric acid to try to 
dissolve more calcium.  Although a pH of 3 has the highest calcium solubility for the 
baseline formulation with H2SO4, this pH was found to be ineffective against a mold 
challenge in pretreated urine in a separate test.  No oxidizer was used in this test. 
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Figure 1:  Solubility of Gypsum in Inorganic-Organic Brine Ersatz 
 
3.2 TEST 2 
Testing with the ersatz brine in Test 1 confirmed that the alternative acids were effective 
at increasing the solubility of gypsum (calcium sulfates) in ersatz brine solutions 
compared to the baseline acid (sulfuric acid) by a factor of about two.  Test 1 was 
conducted by equilibrating artificial urine brine solutions with an excess of gypsum 
crystals and measuring the amount of calcium that would dissolve.  The next step was 
to evaluate the more realistic processes of gypsum solubility in brines during the 
distillation of real urine solutions with calcium concentrations representing the upper 95th 
percentile (PTAU95). 
Experiments were conducted to evaluate the effectiveness of the alternative acids at 
preventing precipitation of minerals during distillation of real urine.  The question to be 
answered was if the alternative acids would permit distillation of PTAU95 to 85% 
recovery without precipitation of minerals.  The effect of three different oxidizer 
(hexavalent chromium) concentrations were measured:  (1) no oxidizer, (2) the reduced 
oxidizer dose (0.002 M), and (3) the baseline oxidizer dose (0.015 M) in pretreated 
urine.  The main parameter used to monitor the quantity of mineral precipitates was the 
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mass concentration of FSS.  In addition, the mass concentration of VSS was measured 
to quantify the precipitation of uric acid, a poorly soluble organic compound found in 
urine.  The goal was to determine the type of acid (H2SO4, H3PO4, HCl, and HNO3), the 
required alternate acid doses to reach the equivalent pH of the baseline pretreatment 
formulation using sulfuric acid (pH 2), and the oxidizer concentration (0.0 M, 0.002 M, 
and 0.0015 M) that minimized both inorganic and organic precipitates (TSS) in 85% 
recovery brines. 
Figures 2 and 3 show the effect of pretreatment formulations on TSS in real brines. 
Figure 2 shows the mass concentration of FSS and VSS in brines that were distilled to 
85% recovery from PTAU95 that was acidified but not oxidized. 
Without an oxidizer, uric acid precipitates at 1 to 2 g/kg of brine for all acids, including 
the baseline sulfuric acid.  The formation of uric acid crystals in acidified urine brines is 
a slow process compared to the formation of gypsum crystals.  The induction time is on 
the order of 1 week for uric acid crystals to form from supersaturated urine solutions.  
Uric acid is poorly soluble and will precipitate in pretreated urine even without 
distillation.  In this study, uric acid crystals were identified based on their amber color 
and morphology. 
Figure 3 shows that the alternative acids prevent mineral precipitation up to 85% water 
recovery.  The error bars represent ± one standard deviation for triplicate distillations of 
PTAU95.  FSS values are less than 30 mg/kg of brine for all three alternative acids 
compared to an average FSS of 1.9 g/kg for the baseline sulfuric acid.  The VSS values 
are less than 125 mg/kg of brine for all three alternative acids and 320 (reduced oxidizer 
dose) to 580 mg/kg (full oxidizer dose) for the sulfuric acid brine. 
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Figure 2:  Suspended Solids in 85% Brines Without Oxidizer 
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Figure 3:  Suspended Solids in 85% Brines With Oxidizer 
The concentration of dissolved calcium ions was measured for all the filtered brines 
after being stored for 1 week.  All of the alternative acid brines at 85% recovery had 
dissolved concentrations of about 1,400 mg-Ca/L compared to 700 mg-Ca/L for the 
baseline pretreatment brine with sulfuric acid. 
 
 
4 Recommended Formulations 
 
The new formulations would utilize the same hardware that is currently used on ISS.  
The current pretreatment formulation is launched and transported in a 5-L tank that links 
to the pretreatment/water dispenser pump of the Russian toilet in the WHC.  The new 
formulations prepared with phosphoric acid or nitric acid would use the same 5-L tank.  
In the case of hydrochloric acid, two separate tanks would be required because 
concentrated hydrochloric acid is not compatible with oxidizer.  The relative 
compositions of the formulations are listed in Table 6.  Dosing requirements to achieve 
equivalent pH values as the current baseline pretreatment are given in Tables 7 through 
10. 
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Similar to the current pretreatment formulation using sulfuric acid, the new formulations 
combine a concentrated acid with an aqueous solution of hexavalent chromium.  Proper 
Personal Protective Equipment (PPE) and safe laboratory practices in a fume hood are 
required to prepare and store these solutions. 
One liter of the new pretreatment solution using phosphoric acid is prepared by 
dissolving 24.3 g of CrO3 in 147 mL of DI water.  Next, 853 mL of 85% phosphoric acid 
are added to the 147 mL of chromium solution to make 1 L of stabilizer.  The 
pretreatment solution is 89.4% concentrated phosphoric acid (includes water contained 
in concentrated phosphoric acid), 9.1% water (used to dissolve CrO3), and 1.5% 
chromium trioxide by mass.  Five liters of this solution are required to fill the 
pretreatment tank on ISS.  Five liters of solution are sufficient to stabilize 254 L of raw 
urine. 
One liter of the new pretreatment solution using nitric acid is prepared by dissolving 
47 g of CrO3 in 284 mL of DI water.  Next, 716 mL of 70% nitric acid are added to the 
284 mL of chromium solution to make 1 L of pretreatment solution.  The pretreatment 
solution is 73.4% concentrated nitric acid (includes water contained in concentrated 
nitric acid), 21.2% water, and 3.5 % chromium trioxide by mass.  Five liters of this 
solution are required to fill the pretreatment tank on ISS and will stabilize 490 liters of 
raw urine.  Due to the hazardous nature of nitric acid and its potential decomposition 
into oxides of nitrogen when exposed to air, the nitric acid formulation would be more 
hazardous than the current formulation utilizing sulfuric acid. 
Table 6:  Relative Mass Content of Stabilizer Solutions in 5-Liter Tank Prior to 
Pretreatment of Urine 
 
Mass Density of 
Stabilizer Solution  
at 20 °C 
Concentrated 
Acid Solution
Water to 
Dissolve CrO3
CrO3 
Baseline stabilizer 
solution with 98% H2SO4 1.35 g/mL 36.5% 54.5% 9.0% 
Alternative stabilizer 
solution with 85% H3PO4 1.62 g/mL 89.4% 9.1% 1.5% 
Alternative stabilizer 
solution with 70% HNO3 1.35 g/mL 75.4% 21.1% 3.5% 
Alternative stabilizer 
solutions with 37% HCl 
1.20 g/mL 100% 0% 0% 
1.17 g/mL 0% 85.8% 14.2%
Note:  Percentages by mass. The formulation with HCl would require two separate tanks (one 
for the acid and one for the oxidizer solution). 
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Due to oxidation of chloride ions by chromic acid, hydrochloric acid is not compatible 
with the oxidizer solution at the tested concentrations; the oxidizer solution and 
concentrated acid would have to be added separately to the urine if hydrochloric acid 
were to replace sulfuric acid.  The high vapor pressure and corrosiveness of 37% 
hydrochloric acid would also be problematic for flight applications. 
Long-term stability of the alternative stabilizer solutions during storage and materials 
compatibility were not included in this testing. 
Table 7:  Volume and Mass of Stabilizer Solutions To Be Injected in Each Dose 
With Flush Water 
Nominal Doses per 
Liter of Raw Urine 
Based on 
9 Returned RFTAs 
Acid 
mL-Stabilizer 
Solution per Dose  
(1 injection) 
mL-Flush Water  
per Dose  
(1 injection) 
5.3 
98% H2SO4 (current 
baseline operations 
on ISS) 
3.0 50 
5.3 85% H3PO4 3.7 50 
5.3 70% HNO3 1.9 50 
5.3 37% HCl 2.5 50 
 
Table 8:  Concentrations of Stabilizer Chemicals Relative to Raw Urine 
for Nominal Dosing 
Acid g-Pure Acid per kg of  Raw Urine 
g-Cr per kg of  
Raw Urine 
98% H2SO4 (current baseline 
operations on ISS) 7.7 g-H2SO4/kg 1.0 g-Cr/kg 
85% H3PO4 24.2 g-H3PO4/kg 0.25 g-Cr/kg 
70% HNO3 7.2 g-HNO3/kg 0.25 g-Cr/kg 
37% HCl 5.9 g-HCl/kg 0.25 g-Cr/kg 
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Table 9:  Concentrations of Stabilizer Solution Volumes and Masses Relative to 
Raw Urine for Nominal Dosing 
Acid g-Stabilizer Solution per kg of Raw Urine 
mL-Stabilizer Solution per 
kg of Raw Urine 
98% H2SO4 (current baseline 
operations on ISS) 
21.5 g /kg 15.9 mL/kg 
85% H3PO4 31.8 g/kg 19.6 mL/kg 
70% HNO3 13.6 g/kg 10.1 mL/kg 
37% HCl  15.9 g/kg 13.3 mL/kg 
 
The values listed in Tables 8 and 9 are based on obtaining a pH of 2 in the pretreated 
95th-percentile urine.  If the requirement can be increased to a pH greater than 2 in the 
future by additional testing, the mass of stabilizer solutions could be reduced.  This 
would require brine precipitation testing and a long-term bacteria and mold challenge 
test at a pretreated urine pH of about 2.2 to 2.3. 
Table 10:  Concentrations of Stabilizer Chemicals in Flushed, Pretreated Urine 
(PTU) for Nominal Dosing 
Acid g-Pure Acid per kg of PTU g-Cr per kg of PTU 
98% H2SO4 (current baseline 
operations on ISS) 6.0 g-H2SO4/kg-PTU 0.78 g-Cr/kg-PTU 
85% H3PO4 18.6 g-H3PO4/kg-PTU 0.19 g-Cr/kg-PTU 
70% HNO3 5.6 g-HNO3/kg-PTU 0.19 g-Cr/kg-PTU 
37% HCl 4.6 g-HCl/kg-PTU 0.19 g-Cr/kg-PTU 
 
5. Summary and Conclusions 
 
Three different strong acids were substituted for sulfuric acid in the urine pretreatment 
formulation.  These alternative acids eliminated the excess of sulfate ions coming from 
sulfuric acid that reduce the solubility of calcium in brines.  The concentrated acids 
studied were 85% phosphoric, 37% hydrochloric, and 70% nitric acid. The effect of 
lowering the oxidizer concentration also was studied in order to save consumable mass 
and improve distillate water quality.  This paper summarized the test results and defined 
the new formulations and the injection masses required to stabilize urine.  The tested 
pretreatment concentrations were effective at preventing precipitation of gypsum and 
other minerals up to 85% water recovery from PTAU95. 
Phosphoric acid is recommended as the safest alternative acid to replace sulfuric acid.  
It also is recommended that the injected mass concentration of chromium trioxide 
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solution be reduced by 75% to minimize resupply mass and reduce elevations in brine 
pH associated with oxidation processes. 
By enabling UPA operations at 85% water recovery instead of the current 70%, the new 
formulation with phosphoric acid would permit recovery of an additional 193 g of water 
per kg of raw urine compared to the pretreatment formulation currently used on ISS.  
For a crew of three astronauts on ISS for 1 year, this equates to 274 kg of additional 
water from urine.  The new formulation also would reduce the mass of brine produced 
by the UPA by 193 g/kg of raw urine processed, corresponding to a reduction of 274 kg 
of hazardous brine per year for a crew of three.  The required mass of pretreatment 
solution will increase from 21.5 g/kg of raw urine to 31.9 g/kg for the phosphoric acid 
formulation.  This corresponds to an annual liquid mass increase from 30.6 kg of the 
current sulfuric acid pretreatment to 45.4 kg of the new phosphoric acid solution for a 
crew of three. 
Implementation of the pretreatment would not require major hardware changes.  The 
new urine stabilizer solution could be launched, stored, and delivered in the 5-L 
pretreatment tank that is currently used for the sulfuric acid pretreatment solution on 
ISS.  Volumes of 3.7 mL of pretreatment solution and 50 mL of flush water would be 
injected in one dose by the pretreat/water dispenser pump upstream of the fan 
separator in the Russian toilet (compared to the current 3.0 mL baseline injection dose).  
Five liters (8.1 kg) of the new solution are sufficient to stabilize 254 L of raw urine 
(65 day supply for a crew of three).  As a comparison, 5 L (6.8 kg) of the prior urine 
pretreatment solution with sulfuric acid were sufficient to stabilize 315 kg of raw urine 
(81 day supply).   
Future testing with a 3.0 mL injection of the phosphoric acid formulation are planned to 
determine if it is sufficient to stabilize urine and prevent mineral precipitation in brines. 
The formulations and data in this document were tested on a limited number of 
artificially augmented urine batches collected from employees at JSC.  This work 
demonstrated the desired physical and chemical stability of pretreated urine under 
laboratory conditions.  Additional testing will be required to determine the feasibility of 
utilizing the proposed pretreatment formulations on ISS.  Continued collection of 
statistical data on in-flight urinary concentrations of calcium, sulfate, and phosphate 
would be helpful in assessing the precipitation potential of any given pretreatment 
formulation. 
To summarize, the main conclusions for each alternative acid were: 
A. Based on experimental results and practical considerations, phosphoric acid is 
the safest alternative acid of the three tested to replace sulfuric acid. 
B. The formulation with nitric acid was also effective at preventing mineral 
precipitation in 85% brines and stabilizing urine with a low resupply mass 
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requirement, but concentrated nitric acid is considered to be more hazardous and 
less stable than phosphoric acid.  Ammonium nitrate salts also present safety 
issues if brines were distilled to dryness. 
C. Hydrochloric acid was effective at preventing precipitation in 85% brines and 
stabilizing urine with a very low resupply mass requirement , but it reacts with 
hexavalent chromium, so it would have to be stored and injected separately from 
the oxidizer solution.  Concentrated hydrochloric acid also has a high vapor 
pressure and is corrosive. 
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